Sign in
SuspendedNo phase

Cryotherapy & Oxaliplatin

Key facts

Who runs it
NYU Langone Health
Where
Mineola and New York, United StatesSee the 2 sites
Trial code
Status
Suspended
People taking part
40 people, planned
Started
13 Mar 2025
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Cryotherapy Gloves
Record updated
6 March 2026
Why it stopped
Study paused to enrollment

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Over the age of 18 years
  • Willingness to participate in research
  • Diagnosed with stage III colon cancer
  • Chemotherapy naïve
  • Planning to initiate Capecitabine + Oxaliplatin (CAPOX) chemotherapy regimen as part of standard of care

Who cannot take part

  • Pre-existing diabetes
  • Raynaud's disease
  • Metabolic syndrome, including: Hypertension; Hypercholesterolemia; and Obesity (BSA > 2)
  • Specific autoimmune diseases: Guillain-Barre; Lupus; Rheumatoid arthritis; and Sjogren's syndrome
  • Pre-existing peripheral neuropathy
  • Upper extremity amputees

Where in United States

  • NYU Langone HealthMineola, United States
  • NYU Langone HealthNew York, United States

About the trial

What the trial wants to find out

The primary objective of this study is to determine if cryotherapy is beneficial to patients with colon cancer who are receiving oxaliplatin in the prevention of developing chemotherapy induced peripheral neuropathy.

The 2 groups in the trial

  • CryotherapyTreatment being tested

    Patients receiving oxaliplatin who are randomized to the Interventional (Cryotherapy) Arm will wear a pair of gloves that has removable ice packs throughout their treatment, starting 15 minutes before and ending 15 minutes after completion of oxaliplatin. These ice packs will be replaced every 30 minutes. The total wearing time of the cryotherapy will be approximately 2 hours.

    Treatment: Cryotherapy Gloves

  • ControlNo study treatment, for comparison

    Patients receiving oxaliplatin who are randomized to the Control Arm will not receive the gloves with removable ice packs throughout their treatment.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Phase II Randomized Interventional Pilot Study for Colon Cancer Patients Receiving Oxaliplatin: Benefits of Cryotherapy in Prevention of Peripheral Neuropathy
Record updated
6 March 2026